CRESCENT BIOPHARMA, INC. (CBIO) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-30 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-15 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-14 | 8-K | Results of Operations | SEC |
| 2026-06-03 | 8-K | Shareholder Vote Results | SEC |
| 2026-04-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-12-04 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-31 | 8-K | Results of Operations, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Material Agreement, Acquisition or Disposition, Results of Operations, Item 3.03, Auditor Change, Change in Control, Officer / Director Changes, Charter Amendments, Item 5.05, Item 5.06, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-06 | 8-K | Shareholder Vote Results, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-05-30 | 8-K | Other Events | SEC |
| 2025-04-29 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-02-25 | 8-K | Termination of Agreement, Officer / Director Changes | SEC |
| 2025-02-14 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-01-31 | 8-K | Officer / Director Changes | SEC |
| 2025-01-13 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-12-26 | 8-K | Listing Notice | SEC |
| 2024-11-07 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-29 | 8-K | Material Agreement, Unregistered Sales, Change in Control, Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-30 | 8-K | Item 2.05, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-06-26 | 8-K | Listing Notice | SEC |
| 2024-06-13 | 8-K | Officer / Director Changes | SEC |
| 2024-06-04 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-06 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-02 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-03-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-01 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-02 | 8-K | Material Agreement | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.